ReVision Implant
PrivateLast Round
Seed
May 26, 2026
Total Funding Raised
$7.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ReVision Implant operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Seed round in May 2026.
ReVision Implant is a neurotechnology company developing a cortical visual prosthesis to restore functional vision in people with severe blindness by transmitting video directly to the brain's visual cortex.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReVision Implant Comparables
Compare ReVision Implant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phosphoenix | 93% | |
| Vivani Medical | 82% | |
| Neuralink | 75% |
For institutional investors. Book with your work email.
ReVision Implant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 26, 2026 | ||||
| Grant | Jan 11, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ReVision Implant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Plug and Play Tech Center | Seed |
| imec.istart | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$4.65M raised in early funding.
- Feb 16, 2026
Grew 67% QoQ, from 6 to 10 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 24, 2026
Revision Implant, based in Belgium, is developing a brain implant aimed at helping restore sight in blind people.
For institutional investors. Book with your work email.
ReVision Implant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReVision Implant's valuation, stock price, and market status.
Is ReVision Implant a public or private company?
ReVision Implant is a private company.
What is the current stock price of ReVision Implant?
ReVision Implant is a private company, so its shares have no public market price. Caplight tracks ReVision Implant's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReVision Implant worth (valuation)?
Valuation information for ReVision Implant is not publicly available.
Can I buy ReVision Implant stock?
ReVision Implant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReVision Implant's last funding round?
ReVision Implant's most recent funding round was Seed on May 26, 2026.
Who are the main investors in ReVision Implant?
Key investors in ReVision Implant include European Innovation Council Fund, Plug and Play Tech Center, imec.istart.
Will ReVision Implant IPO soon?
No public IPO plans have been announced for ReVision Implant.
How can I track ReVision Implant secondary market activity?
Caplight tracks bids, offers, and trades in ReVision Implant's shares on secondary markets.